A Precision Purification Technology For Microbial Biologics

By Kenneth Holbourn, Senior Director, Process Development

Downstream purification remains one of the most persistent challenges in microbial biologics, particularly when suitable affinity resins are unavailable. As expression systems deliver increasingly complex proteins, purification strategies must evolve to keep pace without adding unnecessary complexity or risk. A precision purification approach is emerging that introduces a standardized affinity capture step while preserving the native protein sequence. By enabling clean, scarless tag removal, this strategy avoids residual amino acids that can compromise structure, function, or regulatory confidence.

The approach is designed to integrate seamlessly into existing microbial workflows and scale efficiently into cGMP manufacturing. Rather than relying on multi-step, highly customized purification schemes, it emphasizes platform consistency—reducing development time, improving reproducibility, and simplifying downstream process design. Regulatory considerations are addressed through clear characterization, demonstrated tag removal, and robust impurity clearance strategies.

For teams developing microbial-expressed biologics, explore how this model offers a practical path to faster process development with fewer tradeoffs between speed, quality, and scalability.